Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Comparison of Characteristics and 3-Year Outcomes in Patients With Acute Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.

Cho JH, Choe WS, Cho HJ, Lee HY, Jang J, Lee SE, Choi JO, Jeon ES, Kim MS, Hwang KK, Chae SC, Baek SH, Kang SM, Choi DJ, Yoo BS, Kim KH, Cho MC, Kim JJ, Oh BH.

Circ J. 2018 Nov 6. doi: 10.1253/circj.CJ-18-0543. [Epub ahead of print]

2.

Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?

Webb J, Draper J, Fovargue L, Sieniewicz B, Gould J, Claridge S, Barton C, Smith S, Tondel K, Rajani R, Kapetanakis S, Rinaldi CA, McDonagh TA, Razavi R, Carr-White G.

Int J Cardiol Heart Vasc. 2018 Sep 6;21:1-6. doi: 10.1016/j.ijcha.2018.06.001. eCollection 2018 Dec.

3.

Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) study.

Persson H, Donal E, Lund LH, Matan D, Oger E, Hage C, Daubert JC, Linde C; KaRen Investigators.

Int J Cardiol. 2019 Jan 1;274:202-207. doi: 10.1016/j.ijcard.2018.06.078. Epub 2018 Jun 20.

PMID:
30049496
4.

Heart failure with mid-range ejection fraction and with preserved ejection fraction.

Petutschnigg J, Edelmann F.

Herz. 2018 Aug;43(5):392-405. doi: 10.1007/s00059-018-4729-8.

PMID:
29955907
5.

Sex, drugs, and heart failure: a sex-sensitive review of the evidence base behind current heart failure clinical guidelines.

Levinsson A, Dubé MP, Tardif JC, de Denus S.

ESC Heart Fail. 2018 Oct;5(5):745-754. doi: 10.1002/ehf2.12307. Epub 2018 Jun 19. Review.

7.

Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology.

Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge-Caballero E, De Jonge N, Frigerio M, Hamdan R, Hasin T, Hülsmann M, Nalbantgil S, Potena L, Bauersachs J, Gkouziouta A, Ruhparwar A, Ristic AD, Straburzynska-Migaj E, McDonagh T, Seferovic P, Ruschitzka F.

Eur J Heart Fail. 2018 Nov;20(11):1505-1535. doi: 10.1002/ejhf.1236. Epub 2018 Jul 17.

PMID:
29806100
8.
9.

Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.

Moliner P, Lupón J, Barallat J, de Antonio M, Domingo M, Núñez J, Zamora E, Galán A, Santesmases J, Pastor C, Bayes-Genis A.

Int J Cardiol. 2018 Apr 15;257:188-192. doi: 10.1016/j.ijcard.2018.01.119. Epub 2018 Jan 31.

PMID:
29415801
10.

Pharmacological treatments for heart failure with preserved ejection fraction-a systematic review and indirect comparison.

Bonsu KO, Arunmanakul P, Chaiyakunapruk N.

Heart Fail Rev. 2018 Mar;23(2):147-156. doi: 10.1007/s10741-018-9679-y. Review.

PMID:
29411216
11.

Pulmonary Hypertension secondary to Left Heart Disease.

Kabbach G, Mukherjee D.

Curr Vasc Pharmacol. 2018;16(6):555-560. doi: 10.2174/1570161115666170913105424.

PMID:
28901848
12.
13.

Who are patients classified within the new terminology of heart failure from the 2016 ESC guidelines?

Delepaul B, Robin G, Delmas C, Moine T, Blanc A, Fournier P, Roger-Rollé A, Domain G, Delon C, Uzan C, Boudjellil R, Carrié D, Roncalli J, Galinier M, Lairez O.

ESC Heart Fail. 2017 May;4(2):99-104. doi: 10.1002/ehf2.12131. Epub 2017 Jan 31.

14.

New Classification for Heart Failure with Mildly Reduced Ejection Fraction: Greater clarity or more confusion?

Nadar S.

Sultan Qaboos Univ Med J. 2017 Feb;17(1):e23-e26. doi: 10.18295/squmj.2016.17.01.005. Epub 2017 Mar 30.

15.

Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.

De Vecchis R, Cesaro A, Ariano C.

Minerva Cardioangiol. 2018 Oct;66(5):659-670. doi: 10.23736/S0026-4725.17.04382-1. Epub 2017 Apr 10.

PMID:
28398017
16.

Value of serum N-terminal B-type natriuretic peptide in asymptomatic structural heart disease in Taiwanese population: Comparisons with current ESC Guidelines.

Hung TC, Wang KT, Yun CH, Kuo JY, Hou CJ, Liu CY, Wu TH, Bezerra HG, Cheng HY, Hung CL, Yeh HI.

Int J Cardiol. 2017 Mar 15;231:195-200. doi: 10.1016/j.ijcard.2016.12.180. Epub 2016 Dec 29.

PMID:
28087179
17.

[The new ESC Guidelines for acute and chronic heart failure 2016].

Oeing CU, Tschöpe C, Pieske B.

Herz. 2016 Dec;41(8):655-663. Review. German.

PMID:
27858115
18.

Overdiagnosis of heart failure in primary care: a cross-sectional study.

Valk MJ, Mosterd A, Broekhuizen BD, Zuithoff NP, Landman MA, Hoes AW, Rutten FH.

Br J Gen Pract. 2016 Aug;66(649):e587-92. doi: 10.3399/bjgp16X685705. Epub 2016 Jun 6.

19.

Impact of using different guideline recommended serum natriuretic peptide thresholds on the diagnosis and referral rates of a diagnostic heart failure clinic.

Fazal IA, Bhagra SK, Bailey KM, Dermot Neely R, MacGowan GA, Skinner JS.

Int J Clin Pract. 2015 Nov;69(11):1349-56. doi: 10.1111/ijcp.12694. Epub 2015 Jul 21.

PMID:
26194330
20.

The EJHF last Editor's legacy: how can a high impact factor be built?

Metra M.

ESC Heart Fail. 2015 Jun;2(2):50-57. doi: 10.1002/ehf2.12032. Epub 2015 Apr 29.

PMID:
28834654

Supplemental Content

Loading ...
Support Center